medigraphic.com
ISSN 1405-1710 (Print)

2016, Number 3

<< Back Next >>

Rev Cent Dermatol Pascua 2016; 25 (3)

Neoformation on back of hand

Trejo AJR, López CLD, Ramos GJA, Medina BA, Alcalá PD, Torres GS, Cardona HMÁ, Hernández BB

Language: Spanish
References: 18
Page: 106-111
PDF size: 234.54 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Mun JH, Kim SH, Jung DS, Ko HC, Kwon KS, Kim MB. Dermatoscopic features of Bowen’s disease in Asians. J Eur Acad Dermatol Venereol. 2010; 24: 805-810.

  2. Westers-Attema A, Van Den Heijkant F, Lohman B, Nelemans P, Winepenninckx V, Kelleners-Smeets N et al. Bowen’s disease: a six-year retrospective study of treatment with emphasis on resection margins. Acta Derm Venerol. 2014; 94: 431-435.

  3. Bolognia JL, Jorizzo JL, Rapini RP. Queratosis actínica, carcinoma basocelular y carcinoma epidermoide. Dermatología. España: Ed. Mosby; 2004. pp. 1677-1695.

  4. Leivovitch I, Huilgol SC, Selva D, Richards S, Paver R. Cutaneous squamous carcinoma in situ (Bowen’s disease): treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005; 52: 997-1002.

  5. Gutiérrez-Mendoza D, Narro-Llorente R, Karam-Orantes M, Fonte-Avalos V, Martínez-Luna E, Toussaint-Caire S et al. Dermoscopy clues in pigmented Bowen’s disease. Dermatol Res Pract. 2010. doi: 10.1155/2010/464821

  6. Gahalaut P, Kant RM, Mishra N, Chauhan S. Multiple pigmented Bowen’s disease: a diagnostic and therapeutic dilemma. Case Rep Oncol Med. 2012. doi: 10.1155/2012/342030

  7. Moreno G, Chia AL, Lim A, Shumack S. Therapeutic options for Bowen’s disease. Australas J Dermatol. 2007; 48: 1-8.

  8. Cox NH, Eedy DJ, Morton CA. Guidelines for management of Bowen’s disease: 2006. Br J Dermatol. 2007; 156: 11-21.

  9. Morton CA, Birnie AJ, Eedy DJ. British Association of Dermatologist’s guidelines for the management of squamous cell carcinoma in situ (Bowen’s disease) 2014. Br J Dermatol. 2014; 170: 245-260.

  10. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013; 68: 957-966. doi: 10.1016/j.jaad.2012.11.037

  11. Attili SK1, Ibbotson SH. How we treat Bowen’s disease with topical photodynamic therapy in Dundee. Photodiagnosis Photodyn Ther. 2009; 6: 41-45.

  12. Aldabagh B, Angeles JG, Cardones AR, Arron ST. Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg. 2013; 39: 1-23.

  13. García MI, Pérez GA, Camacho FM. Úlcera de Marjolin: carcinoma sobre cicatriz por quemadura. Actas Dermosifiliorg. 2006; 97: 529-532.

  14. Mitsuishi T, Kawana S, Kato T, Kawashima M. Human papillomavirus infection in actinic keratosis and Bowen’s disease: comparative study with expression of cell-cycle regulatory proteins p 21 waf1/cip1, p53, PCNA, ki-67, and Bcl-2 in positive and negative lesions. Human Pathology. 2003; 34: 886-892.

  15. Nuño GA, Vicente MF, Pinedo MF, López EJ. Carcinoma epidermoide cutáneo de alto riesgo. Actas Dermosifiliorg. 2012; 103: 567-578.

  16. Mun JH, Park JM, Song M, Jwa SW, Kim HS, Ko HC et al. The use of dermatoscopy to monitor therapeutic response of Bowen disease: a dermatoscopic pathological study. Br J Dermatol. 2012; 167: 1382-1385.

  17. Gaitanis G, Mitsou G, Tsiouri G, Alexis I, Bassukas ID. Cryosurgery During imiquimod cream treatment (“immunocryosurgery”) for Bowen’s disease of the skin: a case series. Letters to the Editor. Acta Derm Venerol. 2010; 9: 533-534.

  18. Martínez EV, Ramos GA, Valencia AM. Enfermedad de Bowen. Rev Cent Dermatol Pascua. 2011; 20: 104-109.




2020     |     www.medigraphic.com